A Targeted Approach to HealthCare
Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.
For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in health care.
Bayer News Releases
28 June 2010 - Bayer News Releases....... Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing their Treatment more
17 June 2010 - Bayer News Releases....... Teva Admits to Making False Statements in US Gianvi™ Label and Agrees to Corrective Measures more
15 June 2010 - Bayer News Releases....... Bayer Sues Teva and Barr for False Advertising and Patent Infringement in Connection with Teva’s Generic Oral Contraceptive GianviTM more
14 June 2010 - Bayer News Releases....... Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival more
17 May 2010 - Bayer News Releases....... Bayer HealthCare Enhances U.S. Research Strategy with New Innovation Center more
6 May 2010 - Bayer News Releases....... U.S. FDA APPROVES NATAZIATM, A NEW ORAL CONTRACEPTIVE FOR THE PREVENTION OF PREGNANCY more
17 April 2010 - Bayer News Releases....... Bayer HealthCare Marks 2010 World Hemophilia Day with a $350,000 Contribution to the World Federation of Hemophilia more
9 April 2010 - Bayer News Releases....... BAYER UPDATES LABELS FOR YAZ and YASMIN Body of Evidence Affirms VTE Risk/Benefit Profile for YAZ and Yasmin Is Comparable to Other Combination Oral Contraceptives more
11 March 2010 - Bayer News Releases....... FDA Grants Bayer HealthCare Pharmaceuticals Orphan Drug Designation for Investigational Ciprofloxacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis more
Further Information
Important Cipro® Safety Information Information for US Healthcare Professionals and Patients
Medication Guide for PatientsUpdated Cipro tablet and oral suspension prescribing information
Updated Cipro Intravenous Prescribing Information
Dear Healthcare Professional Letter
Important Avelox® Safety Information for US Healthcare Professionals and Patients
Medication Guide for PatientsUpdated Avelox Prescribing Information
Dear Healthcare Professional Letter
Important Trasylol® Safety Information
New - Important Information for Health ProfessionalsClinical Trials
Information about clinical studies is available in the Bayer HealthCare database as well as at clinicaltrials.govand clinicalstudyresults.org.
Bayer Reports Findings of Trasylol Independent Investigation
Press StatementInvestigator Report
Key Committees - Bayer Global Drug Safety

